A detailed history of Legacy Wealth Asset Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Legacy Wealth Asset Management, LLC holds 6,485 shares of BNTX stock, worth $791,948. This represents 0.23% of its overall portfolio holdings.

Number of Shares
6,485
Previous 6,641 2.35%
Holding current value
$791,948
Previous $788,000 6.35%
% of portfolio
0.23%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025

SELL
$99.72 - $122.68 $15,556 - $19,138
-156 Reduced 2.35%
6,485 $738,000
Q3 2024

Oct 23, 2024

SELL
$78.36 - $124.66 $3,761 - $5,983
-48 Reduced 0.72%
6,641 $788,000
Q2 2024

Aug 14, 2024

BUY
$80.36 - $102.87 $13,179 - $16,870
164 Added 2.51%
6,689 $537,000
Q1 2024

Apr 19, 2024

BUY
$88.96 - $112.35 $580,464 - $733,083
6,525 New
6,525 $601,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $29.6B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Legacy Wealth Asset Management, LLC Portfolio

Follow Legacy Wealth Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Wealth Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Wealth Asset Management, LLC with notifications on news.